Edgestream Partners, L.P. Amarin Corp Plcuk Transaction History

Edgestream Partners, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$1.13 - $3.69 $128,826 - $420,682	114,006 Added 22.07%	630,512 $939,000
Q1 2022 May 13, 2022	SELL	$2.85 - $3.73 $304,100 - $397,998	-106,702 Reduced 17.12%	516,506 $1.7 Million
Q4 2021 Feb 15, 2022	SELL	$3.24 - $5.18 $768,894 - $1.23 Million	-237,313 Reduced 27.58%	623,208 $2.1 Million
Q3 2021 Nov 15, 2021	SELL	$3.94 - $5.84 $2.63 Million - $3.91 Million	-668,726 Reduced 43.73%	860,521 $4.39 Million
Q2 2021 Aug 10, 2021	SELL	$4.26 - $6.5 $749,602 - $1.14 Million	-175,963 Reduced 10.32%	1,529,247 $6.7 Million
Q1 2021 May 06, 2021	BUY	$5.03 - $8.8 $8.58 Million - $15 Million	1,705,210 New	1,705,210 $10.6 Million

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Edgestream Partners, L.P. with notifications on news.